FIELD: medicine.
SUBSTANCE: in patient obtaining basic anti-inflammatory therapy with combination of inhalation glucocorticosteroid and β2-aginist of long action, level of obtaining control of bronchial asthma is determined by criteria GINA 2006. After that, additionally determined is expression of CD20 marker. If CD20 expresses 16% and more, carried out anti-asthmatic therapy is considered ineffective, requiring correction, if less than 16% of cells - effective.
EFFECT: application of method makes it possible to subjectively estimate efficiency of carried out anti-asthmatic therapy with combination of IGC and β2-aginist of long action.
1 tbl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF DETERMINING BRONCHIAL ASTHMA CONTROL RATIO | 2010 |
|
RU2422827C1 |
METHOD OF TREATING BRONCHIAL ASTHMA | 2010 |
|
RU2445082C2 |
METHOD OF DETERMINING BRONCHIAL ASTHMA CONTROL RATIO | 2010 |
|
RU2440035C2 |
METHOD OF EVALUATING EFFECTIVENESS BASIC ANTI-INFLAMMATORY THERAPY OF BRONCHIAL ASTHMA IN CHILDREN | 2008 |
|
RU2354970C1 |
EFFICIENCY ESTIMATE OF BASELINE ANTIINFLAMMATORY THERAPY OF BRONCHIAL ASTHMA IN CHILDREN | 2008 |
|
RU2357259C1 |
METHOD OF ACHIEVING CONTROL OVER BRONCHIAL ASTHMA | 2013 |
|
RU2571894C2 |
METHOD OF MEDICAL REHABILITATION OF PATIENTS WITH PARTIALLY CONTROLLED MILD BRONCHIAL ASTHMA | 2017 |
|
RU2655543C1 |
METHOD FOR PREDICTION OF THERAPEUTIC EFFICACY OF SEVERE BRONCHIAL ASTHMA | 2013 |
|
RU2530616C1 |
METHOD OF PREDICTING UNCONTROLLED COURSE OF SEVERE BRONCHIAL ASTHMA | 2011 |
|
RU2470582C1 |
METHOD FOR TREATING BRONCHIAL ASTHMA IN CHILDREN IN ATTACK PERIOD | 2002 |
|
RU2236219C2 |
Authors
Dates
2012-01-10—Published
2010-04-05—Filed